facebook
Subscribe50$/product give away!


Submit an Article to Pharmacy HQ     
Please include the author's name, title, and citations.     

ATAZANAVIR SULFATE capsule


  1. When Used With Other Antiretroviral Medicines To Treat Hiv-1 Infection, Atazanavir Sulfate Capsules May Help:
  2. Do Not Take Atazanavir Sulfate Capsules If You:
  3. Before Taking Atazanavir Sulfate Capsules, Tell Your Healthcare Provider If You:
  4. How Should I Take Atazanavir Sulfate Capsules?
  5. Atazanavir Sulfate Capsules Can Cause Serious Side Effects, Including:
  6. The Most Common Side Effects Of Atazanavir Sulfate Capsules Include:
  7. How Should I Store Atazanavir Sulfate Capsules?
  8. Active Ingredient:
  9. Inactive Ingredients:
  10. Manufactured In Croatia By:
  11. Manufactured For:
  12. Patient Information

When Used With Other Antiretroviral Medicines To Treat Hiv-1 Infection, Atazanavir Sulfate Capsules May Help: 

  • reduce the amount of HIV-1 in your blood. This is called viral load .
  • increase the number of CD4+ (T) cells in your blood that help fight off other infections.

Reducing the amount of HIV-1 and increasing the CD4+ (T) cells in your blood may help improve your immune system. This may reduce your risk of death or getting infections that can happen when your immune system is weak (opportunistic infections).

Atazanavir sulfate capsules do not cure HIV-1 infection or AIDS.You must keep taking HIV-1 medicines to control HIV-1 infection and decrease HIV-related illnesses.

Do Not Take Atazanavir Sulfate Capsules If You: 

  • are allergic to atazanavir or any of the ingredients in atazanavir sulfate capsules.

Before Taking Atazanavir Sulfate Capsules, Tell Your Healthcare Provider If You: 

  • have heart problems
  • have liver problems, including hepatitis B or C virus infection
  • are receiving dialysis treatment
  • have diabetes
  • have hemophilia
  • have any other medical conditions
  • are pregnant or plan to become pregnant. Talk to your healthcare provider about taking atazanavir sulfate capsules during your pregnancy or if you are planning to become pregnant while you are taking atazanavir sulfate capsules.
    • Hormonal forms of birth control, such as injections, vaginal rings or implants, contraceptive patch, and some birth control pills may not work during treatment with atazanavir sulfate capsules.Talk to your healthcare provider about forms of birth control that may be used during treatment with atazanavir sulfate capsules.
    • Pregnancy Registry.There is a pregnancy registry for women who take antiretroviral medicines during pregnancy. The purpose of this registry is to collect information about the health of you and your baby. Talk to your healthcare provider about how you can take part in this registry.
    • After your baby is born,tell your healthcare provider if your baby s skin or the white part of the eyes turns yellow.
  • are breastfeeding or plan to breastfeed.Donot breastfeed if you are taking atazanavir sulfate capsules. You should not breastfeed if you have HIV-1 because of the risk of passing HIV-1 to your baby. Atazanavir can pass into your breast milk. Talk to your healthcare provider about the best way to feed your baby.

Tell your healthcare provider about all the medicines you take,including prescription and over-the-counter medicines, vitamins, and herbal supplements. Some medicines interact with atazanavir sulfate capsules.Keep a list of your medicines to show your healthcare provider and pharmacist.You can ask your healthcare provider or pharmacist for a list of medicines that interact with atazanavir sulfate capsules.Do not start taking a new medicine without telling your healthcare provider.Your healthcare provider can tell you if it is safe to take atazanavir sulfate capsules with other medicines.

How Should I Take Atazanavir Sulfate Capsules? 

  • Take atazanavir sulfate capsules exactly as your healthcare provider tells you to.
  • Do not change your dose or stop taking atazanavir sulfate capsules unless your healthcare provider tells you to.
  • Stay under the care of your healthcare provider during treatment with atazanavir sulfate capsules.
  • Atazanavir sulfate capsules must be used with other antiretroviral medicines.
  • Take atazanavir sulfate capsules 1 time each day.
  • Atazanavir sulfate capsules come as capsules.
  • Take atazanavir sulfate capsules with food.
  • Swallow the capsules whole. Do not open the capsules.
  • If you miss a dose of atazanavir sulfate capsules, take it as soon as you remember. Then take the next dose at your regular time. Do not take 2 doses at the same time.
  • If you take too many atazanavir sulfate capsules, call your healthcare provider or go to the nearest hospital emergency room right away.

When your supply of atazanavir sulfate capsules starts to run low,get more from your healthcare provider or pharmacy. It is important not to run out of atazanavir sulfate capsules. The amount of HIV-1 in your blood may increase if the medicine is stopped for even a short time. The virus may become resistant to atazanavir sulfate capsules and harder to treat.

Atazanavir Sulfate Capsules Can Cause Serious Side Effects, Including: 

  • A change in the way your heart beats (heart rhythm change).Tell your healthcare provider right away if you get dizzy or lightheaded. These could be symptoms of a heart problem.
  • Skin rash.Skin rash is common with atazanavir sulfate capsules but can sometimes be severe. Skin rash usually goes away within 2 weeks without any change in treatment. Severe rash may develop in association with other symptoms which could be serious. If you develop a severe rash or a rash with any of the following symptoms, stop taking atazanavir sulfate capsules and call your healthcare provider right away:
    • general feeling of discomfort or flu-like symptoms
    • fever
    • muscle or joint aches
    • red or inflamed eyes, like pink eye (conjunctivitis)
    • blisters
    • mouth sores
    • swelling of your face
    • painful, warm, or red lump under your skin
  • Yellowing of your skin or the white part of your eyesis common with atazanavir sulfate capsules, and is usually not harmful in adults and infants older than 3 months of age; but it could also be a symptom of a serious problem. These effects may be due to increases in bilirubin levels in your blood (bilirubin is made by the liver). Although these effects may not be damaging to your liver, skin, or eyes, tell your healthcare provider right away if your skin or the white part of your eyes turns yellow.
  • Liver problems.If you have liver problems, including hepatitis B or C infection, your liver problems may get worse when you take atazanavir sulfate capsules. Your healthcare provider will do blood tests to check your liver before you start atazanavir sulfate capsules and during treatment. Tell your healthcare provider right away if you get any of the following symptoms:
    • dark tea-colored urine
    • your skin or the white part of your eyes turns yellow
    • light colored stools
    • nausea
    • itching
    • stomach-area pain
  • Chronic kidney disease.Atazanavir sulfate capsules may affect how well your kidneys work. Your healthcare provider will do blood and urine tests to check your kidneys before you start atazanavir sulfate capsules and during treatment.
  • Kidney stoneshave happened in some people who take atazanavir sulfate capsules. Tell your healthcare provider right away if you get symptoms of kidney stones which may include, pain in your low back or low stomach-area, blood in your urine, or pain when you urinate.
  • Gallbladder problemshave happened in some people who take atazanavir sulfate capsules. Tell your healthcare provider right away if you get symptoms of gallbladder problems which may include:
    • pain in the right or middle upper stomach area
    • fever
    • nausea and vomiting
    • your skin or the white part of your eyes turns yellow
  • Diabetes and high blood sugar (hyperglycemia)have happened or have worsened in some people who take protease inhibitor medicines like atazanavir sulfate capsules. Some people have had to start taking medicine to treat diabetes or have had to change their diabetes medicine.
  • Changes in your immune system (Immune Reconstitution Syndrome)can happen when you start taking HIV-1 medicines. Your immune system may get stronger and begin to fight infections that have been hidden in your body for a long time. Tell your healthcare provider if you start having new symptoms after starting atazanavir sulfate capsules.
  • Changes in body fatcan happen in people taking HIV-1 medicines. These changes may include increased amount of fat in the upper back and neck ( buffalo hump ), breast, and around the main part of your body (trunk). Loss of fat from the legs, arms, and face may also happen. The exact cause and long-term health effects of these conditions are not known.
  • Increased bleeding problems in people with hemophiliahave happened when taking protease inhibitors like atazanavir sulfate capsules.

The Most Common Side Effects Of Atazanavir Sulfate Capsules Include: 

  • nausea
  • dizziness
  • headache
  • muscle pain
  • stomach-area pain
  • diarrhea
  • vomiting
  • depression
  • trouble sleeping
  • fever
  • numbness, tingling, or burning of hands or feet

Tell your healthcare provider if you have any side effect that bothers you or that does not go away.

These are not all the possible side effects of atazanavir sulfate capsules. For more information, ask your healthcare provider or pharmacist.

Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

How Should I Store Atazanavir Sulfate Capsules? 

  • Store atazanavir sulfate capsules at room temperature, 68 to 77 F (20 to 25 C).
  • Keep capsules in a tightly closed container.

Keep atazanavir sulfate capsules and all medicines out of the reach of children.

General information about the safe and effective use of atazanavir sulfate capsules

Medicines are sometimes prescribed for purposes other than those listed in a Patient Information leaflet. Do not use atazanavir sulfate capsules for a condition for which they were not prescribed. Do not give atazanavir sulfate capsules to other people, even if they have the same symptoms that you have. They may harm them. If you would like more information, talk with your healthcare provider. You can ask your pharmacist or healthcare provider for information about atazanavir sulfate capsules that is written for health professionals.


For more information, call 1-888-838-2872.

Active Ingredient: 

atazanavir sulfate

Inactive Ingredients: 

crospovidone, D&C yellow #10 aluminum lake, FD&C blue #1, FD&C blue #1 aluminum lake, FD&C blue #2 aluminum lake, FD&C red #40 aluminum lake, gelatin, iron oxide black, lactose monohydrate, magnesium stearate, propylene glycol, shellac, sodium lauryl sulfate, sorbitan monolaurate, and titanium dioxide. Additionally, the 300 mg capsules also contain FD&C red #40.

Manufactured In Croatia By: 

Pliva Hrvatska d.o.o.

Zagreb, Croatia

Manufactured For: 

Teva Pharmaceuticals USA, Inc.

North Wales, PA 19454

Orapis a registered trademark of Teva Pharmaceuticals USA, Inc.

All brand names listed are the registered trademarks of their respective owners and are not trademarks of Teva Pharmaceuticals USA, Inc.

This Patient Information has been approved by the U.S. Food and Drug Administration.

Rev. D 5/2018

Patient Information 

Advise the patient to read the FDA-approved patient labeling(Patient Information).

Atazanavir sulfate capsules are not a cure for HIV infection. Advise patients to remain under the care of a healthcare provider while using atazanavir sulfate capsules.

Cardiac Conduction Abnormalities
Inform patients that atazanavir may produce changes in the electrocardiogram (e.g., PR prolongation). Tell patients to consult their healthcare provider if they are experiencing symptoms such as dizziness or lightheadedness[see Warnings and Precautions (5.1)].

Severe Skin Reaction
Inform patients that there have been reports of severe skin reactions (e.g., Stevens-Johnson syndrome, erythema multiforme, and toxic skin eruptions) with atazanavir sulfate capsules use. Advise patients that if signs or symptoms of severe skin reactions or hypersensitivity reactions develop, they must discontinue atazanavir sulfate capsules and seek medical evaluation immediately[see Warnings and Precautions (5.2) and Adverse Reactions (6.1)].

Hyperbilirubinemia

Inform patients that asymptomatic elevations in indirect bilirubin have occurred in patients receiving atazanavir sulfate capsules. This may be accompanied by yellowing of the skin or whites of the eyes and alternative antiretroviral therapy may be considered if the patient has cosmetic concerns[see Warnings and Precautions (5.8)].

Chronic Kidney Disease

Inform patients that treatment with atazanavir sulfate capsules may lead to the development of chronic kidney disease, and to maintain adequate hydration while taking atazanavir sulfate capsules[see Warnings and Precautions (5.5)].

Nephrolithiasis and Cholelithiasis
Inform patients that kidney stones and/or gallstones have been reported with atazanavir sulfate use. Some patients with kidney stones and/or gallstones required hospitalization for additional management and some had complications. Discontinuation of atazanavir sulfate capsules may be necessary as part of the medical management of these adverse events[see Warnings and Precautions (5.6)].

Drug Interactions
Atazanavir sulfate capsules may lead to significant interaction with some drugs; therefore, advise patients to report the use of any other prescription, nonprescription medication, or herbal products, particularly St. John s wort, to their healthcare provider prior to use[see Contraindications (4), Warnings and Precautions (5.7)].

Immune Reconstitution Syndrome

Advise patients to inform their healthcare provider immediately of any symptoms of infection, as in some patients with advanced HIV infection (AIDS), signs and symptoms of inflammation from previous infections may occur soon after anti-HIV treatment is started[see Warnings and Precautions (5.10)].

Fat Redistribution

Inform patients that redistribution or accumulation of body fat may occur in patients receiving antiretroviral therapy including protease inhibitors and that the cause and long-term health effects of these conditions are not known at this time[see Warnings and Precautions (5.11)].

Dosing Instructions

Advise patients to take atazanavir sulfate capsules with food every day and take other concomitant antiretroviral therapy as prescribed. Atazanavir sulfate capsules must always be used in combination with other antiretroviral drugs. Advise patients that they should not alter the dose or discontinue therapy without consulting with their healthcare provider. Tell patients if a dose of atazanavir sulfate capsules is missed, they should take the dose as soon as possible and then return to their normal schedule; however, if a dose is skipped the patient should not double the next dose.

Pregnancy
Inform pregnant patients that there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to atazanavir sulfate capsules during pregnancy. Healthcare providers are encouraged to register patients by calling the Antiretroviral Pregnancy Registry[see Use in Specific Populations (8.1)].

Lactation
Instruct women with HIV-1 infection not to breastfeed because HIV-1 can be passed to the baby in the breast milk. Atazanavir can also be passed to the baby in breast milk and it is not known whether it could harm the baby[see Use in Specific Populations (8.2)].

All brand names listed are the registered trademarks of their respective owners and are not trademarks of Teva Pharmaceuticals USA, Inc.



Your use of this website constitutes your agreement to the terms and conditions linked below:
Terms and Conditions | Resources
2017 © Copyright PharmacyHQ.com. Questions?
Please contact: pharmacyhq.mail@gmail.com